Companies: 10,795·Total market cap: $144.5T
Amarin Corporation plc

Amarin Corporation plc

AMRNNASDAQHealthcare● Active
$13.93
+$0.13(+0.94%)
Market Cap$288111042
P/E Ratio
52W High$20.9
52W Low$11.65
Overview

Amarin Corporation plc (AMRN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · AMRN · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.62amrn eps ttm · amrn earnings per shareEarnings history
PE Ratio (TTM)amrn pe ratio ttm · amrn price to earningsPE Ratio deep dive
Revenue (TTM)$214.9Mamrn revenue ttm · amrn annual revenueFull revenue history
Dividend YieldNo Dividenddoes amrn pay dividends · amrn dividend yieldDividend history
Shares Outstanding20.7Mamrn shares outstanding · amrn floatShares outstanding history
Next EarningsJul 29, 2026Est.amrn earnings date · amrn next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$213.6M▼ 6.55% YoY
202320242025
amarin corporation plc revenue · amrn revenue 2025
FY 2025Net Income-$38.8M▲ +52.79% YoY
202320242025
amarin corporation plc net income · amrn profit 2025
FY 2025EPS$-1.80▲ +55.00% YoY
202320242025
amrn eps · amarin corporation plc earnings per share 2025
TTM:Revenue: $214.9MNet Income: -$33.6MEPS: $-1.62View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold18 analystsis amrn a buy · amrn analyst rating
Strong Buy
0
Buy
3
Hold
13
Sell
2
Strong Sell
0
12-Month Price Target
$1.50Low
$13.93Current
$2.17Avg Target84.42% downside
$3.00High
amrn price target · amrn 12 month forecast

Total: 18 · Buy rate: 16.7%

The AMRN analyst consensus is Hold, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $2.17, representing -84.42% downside from the current price of $13.93.

Stock Performance

Full History
1D+0.94%
1W-3.73%
1M-7.44%
3M-0.92%
YTD-0.21%
1Y+12.98%
5Y-85.76%

About Amarin Corporation plc

CEOAaron D. Berg
IPO DateApr 1, 1993
Employees275
CountryIE

Amarin Corporation plc a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, L…

what is amarin corporation plc · amrn stock overview · amarin corporation plc company profile · who is amarin corporation plc ceo · amrn NASDAQ · amarin corporation plc headquarters · amarin corporation plc business segments

About Stock Overview & Key Data

Amarin Corporation plc (AMRN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 1, 1993. As of the latest trading session, AMRN stock price is $13.93, with a market capitalization of $288.1M. The stock has returned +12.98% over the past 12 months and -0.21% year-to-date.

According to 18 Wall Street analysts, the consensus rating for Amarin Corporation plc stock is Hold, with an average 12-month price target of $2.17. In fiscal year 2025, Amarin Corporation plc reported revenue of $213.6M and net income of -$38.8M. For detailed data — including Amarin Corporation plc revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Amarin Corporation plc (AMRN) stock price is $13.93. The stock is traded on NASDAQ under the ticker symbol AMRN. The 52-week range is $11.65 – $20.90.

AMRN stock priceAMRN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice